Strata Critical Medical, Inc. SRTA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -180.95% | 161.67% | 9.80% | 3,038.38% | 66.95% |
| Total Depreciation and Amortization | 596.24% | 150.00% | 180.34% | 33.23% | -21.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 74.00% | -88.46% | 39.17% | -2,324.20% | -53.47% |
| Change in Net Operating Assets | 71.36% | -301.91% | -5,256.09% | 241.91% | -190.03% |
| Cash from Operations | 285.61% | 1,679.27% | -374.14% | -686.89% | -136.35% |
| Capital Expenditure | -11.41% | -98.13% | 59.62% | 68.86% | 86.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -2,822.60% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -121.25% | 31.18% | 169.45% | 6,566.28% | 4,249.66% |
| Cash from Investing | -253.00% | 21.18% | 359.38% | 118.96% | 269.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -78.57% | -13.33% | 22.73% | 490.91% | -36.36% |
| Repurchase of Common Stock | -265.42% | 86.48% | 54.16% | -149.60% | 6.42% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -270.45% | 79.77% | 55.03% | -144.46% | 5.88% |
| Foreign Exchange rate Adjustments | -- | -- | 100.00% | -1,093.55% | 2,257.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -272.17% | 73.03% | 567.08% | -435.95% | 354.07% |